You have 9 free searches left this month | for more free features.

Bortezomib

Showing 1 - 25 of 1,116

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bortezomib, Acute Myeloid Leukemia Trial in Wuhan (DAG pre-excitation regimen with Bortezomib)

Recruiting
  • Bortezomib
  • Acute Myeloid Leukemia
  • DAG pre-excitation regimen with Bortezomib
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 31, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Bortezomib
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Sep 7, 2023

Rheumatoid Arthritis Trial in Beijing (bortezomib)

Not yet recruiting
  • Rheumatoid Arthritis
  • bortezomib
  • Beijing, China
    Peking Union Medical College Hospital
Apr 6, 2023

Immunoglobulin Light-chain Amyloidosis Trial (Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules

Not yet recruiting
  • Immunoglobulin Light-chain Amyloidosis
  • Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
  • Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
  • (no location specified)
Mar 18, 2023

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • Acute Lymphoblastic Leukemia With Failed Remission
  • Bortezomib
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Sep 12, 2023

Bortezomib, Glomerulonephritis, MN Trial in Shanghai (Bortezomib)

Recruiting
  • Bortezomib
  • +5 more
  • Bortezomib
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Oct 28, 2022

Alvocade® (Bortezomib) Safety and Effectiveness Study

Completed
  • Multiple Myeloma, Refractory
  • Bortezomib
  • (no location specified)
Aug 19, 2023

Getting Peripheral Neuropathy in Patients Treated With

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
    • (no location specified)
    Mar 23, 2023

    Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis

    Not yet recruiting
    • Bone Marrow Transplant Complications
    • +4 more
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    May 30, 2023

    Multiple Myeloma Trial in Hackensack (Thalidomide+Melphalan +Bortezomib+stem cell transplant)

    Completed
    • Multiple Myeloma
    • Thalidomide+Melphalan +Bortezomib+stem cell transplant
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    Dec 16, 2022

    Waldenstrom's Macroglobulinemia Trial in Houston (Bortezomib, Rituximab, Valacyclovir)

    Active, not recruiting
    • Waldenstrom's Macroglobulinemia
    • Bortezomib
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 5, 2022

    Relapsed/Refractory Immune Thrombocytopenia Trial in Seoul (Bortezomib)

    Not yet recruiting
    • Relapsed/Refractory Immune Thrombocytopenia
    • Bortezomib
    • Seoul, Korea, Republic of
    • +1 more
    Oct 30, 2022

    Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)

    Recruiting
    • Newly Diagnosed Multiple Myeloma
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Dec 29, 2022

    Multiple Myeloma Trial in Hackensack (Bortezomib)

    Terminated
    • Multiple Myeloma
    • Bortezomib
    • Hackensack, New Jersey
      The Cancer Center at Hackensack University Medical Center
    Jun 24, 2022

    Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

    Not yet recruiting
    • Multiple Myeloma
    • Renal Failure
    • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
    • Augusta, Georgia
      Georgia Cancer Center-Augusta University
    Nov 16, 2023

    Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

    Active, not recruiting
    • Plasma Cell Myeloma
    • Bortezomib
    • +3 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Jan 10, 2023

    Multiple Myeloma Trial (Iberdomide, Bortezomib, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Jul 18, 2022

    Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

    Completed
    • Chronic Myeloid Leukemia (CML)
    • +4 more
    • Bortezomib
    • NK cells
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 31, 2022

    Daratumumab in Combination With Bortezomib, Thalidomide, and

    Not yet recruiting
    • Newly Diagnosed Multiple Myeloma
    • Daratumumab in Combination with Bortezomib, Thalidomide, and Dexamethasone Regimens
    • (no location specified)
    Sep 27, 2022

    Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

    Active, not recruiting
    • Light Chain Deposition Disease
    • Primary Systemic Amyloidosis
    • Denver, Colorado
    • +4 more
    Jan 20, 2023

    Diffuse Large B Cell Lymphoma Trial in Berlin (Ibrutinib and Bortezomib + R-CHOP)

    Active, not recruiting
    • Diffuse Large B Cell Lymphoma
    • Ibrutinib and Bortezomib + R-CHOP
    • Berlin, Germany
      Charité - Universitätsmedizin Berlin, Hematology, Oncology and T
    Aug 10, 2022

    Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)

    Active, not recruiting
    • Solid Tumor
    • Urethral Cancer
    • Bortezomib
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Sep 22, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Bortezomib, Metformin Hydrochloride,

    Active, not recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Bortezomib
    • +2 more
    • Jacksonville, Florida
    • +1 more
    Jan 5, 2023

    Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

    Recruiting
    • Multiple Myeloma
    • Monoclonal Gammopathy of Renal Significance
    • Basking Ridge, New Jersey
    • +6 more
    Oct 16, 2023

    Multiple Myeloma, Myeloma Multiple, Myeloma Trial in Poitiers (Drug and medical device)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Drug and medical device
    • Poitiers, France
      CHU Poitiers
    Jun 1, 2023